石药集团:SYH9102注射液获中国临床试验批准,每月给药一次

智通财经
Sep 09
【石药集团:SYH9102注射液获中国临床试验批准,每月给药一次】石药集团公告,公司开发的戈舍瑞林缓释注射液已获中华人民共和国国家药品监督管理局批准,可在中国开展临床试验;本次获批的临床适应症为用于实体瘤患者,该产品每月给药一次。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10